BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37047822)

  • 1. The Cellular Response to DNA Damage: From DNA Repair to Polyploidy and Beyond.
    Mirzayans R
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence.
    Mirzayans R; Murray D
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.
    Studach L; Wang WH; Weber G; Tang J; Hullinger RL; Malbrue R; Liu X; Andrisani O
    J Biol Chem; 2010 Sep; 285(39):30282-93. PubMed ID: 20624918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleomycin-induced DNA damage and repair in Xenopus laevis and Xenopus tropicalis.
    Banner SH; Ruben LN; Johnson RO
    J Exp Zool A Ecol Genet Physiol; 2007 Feb; 307(2):84-90. PubMed ID: 17171708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of premature liver polyploidy in DNA repair (Ercc1)-deficient mice.
    Chipchase MD; O'Neill M; Melton DW
    Hepatology; 2003 Oct; 38(4):958-66. PubMed ID: 14512883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the Circadian Clock "Death-Loop" in the DNA Damage Response Underpinning Cancer Treatment Resistance.
    Vainshelbaum NM; Salmina K; Gerashchenko BI; Lazovska M; Zayakin P; Cragg MS; Pjanova D; Erenpreisa J
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
    Goldstein M; Kastan MB
    Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.
    Zekri A; Ghaffari SH; Yaghmaie M; Estiar MA; Alimoghaddam K; Modarressi MH; Ghavamzadeh A
    Mol Neurobiol; 2016 Apr; 53(3):1808-1823. PubMed ID: 25752998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond repair foci: subnuclear domains and the cellular response to DNA damage.
    Dellaire G; Bazett-Jones DP
    Cell Cycle; 2007 Aug; 6(15):1864-72. PubMed ID: 17660715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependency of repair of radiation-induced damage on p53 status and efficient inhibition of the repair with wortmannin treatment in vivo, with reference to the effect on intratumor quiescent cell population.
    Masunaga S; Takahashi A; Ohnishi K; Nagata K; Suzuki M; Kashino G; Kinashi Y; Ohnishi T; Ono K
    Oncol Rep; 2007 Dec; 18(6):1589-96. PubMed ID: 17982649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Damage Response and Metabolic Reprogramming in Health and Disease.
    Chatzidoukaki O; Goulielmaki E; Schumacher B; Garinis GA
    Trends Genet; 2020 Oct; 36(10):777-791. PubMed ID: 32684438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNAs in DNA damage response and repair in cancer cells.
    Su M; Wang H; Wang W; Wang Y; Ouyang L; Pan C; Xia L; Cao D; Liao Q
    Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):433-439. PubMed ID: 29554194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DNA damage and repair in radiation cancer therapy: a current update and a look to the future.
    Liu J; Bi K; Yang R; Li H; Nikitaki Z; Chang L
    Int J Radiat Biol; 2020 Nov; 96(11):1329-1338. PubMed ID: 32776818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular response to DNA damage.
    Kao J; Rosenstein BS; Peters S; Milano MT; Kron SJ
    Ann N Y Acad Sci; 2005 Dec; 1066():243-58. PubMed ID: 16533929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage repair and response proteins as targets for cancer therapy.
    Lieberman HB
    Curr Med Chem; 2008; 15(4):360-7. PubMed ID: 18288990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere-related genome instability in cancer.
    De Lange T
    Cold Spring Harb Symp Quant Biol; 2005; 70():197-204. PubMed ID: 16869754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting DNA Repair.
    Curigliano G
    Handb Exp Pharmacol; 2018; 249():161-180. PubMed ID: 30341723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage and repair in translational oncology: an overview.
    Reed E
    Clin Cancer Res; 2010 Sep; 16(18):4511-6. PubMed ID: 20823144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status.
    Pustovalova M; Blokhina T; Alhaddad L; Chigasova A; Chuprov-Netochin R; Veviorskiy A; Filkov G; Osipov AN; Leonov S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.